Analysts Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Price Target at $28.25

Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) has been given an average rating of “Hold” by the twelve analysts that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $28.25.

A number of analysts recently issued reports on WBA shares. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. JPMorgan Chase & Co. raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $27.00 to $30.00 in a research report on Monday, October 23rd. HSBC began coverage on Walgreens Boots Alliance in a research report on Friday, December 22nd. They issued a “hold” rating and a $27.00 target price for the company. Finally, Barclays began coverage on Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 target price for the company.

Check Out Our Latest Report on WBA

Walgreens Boots Alliance Stock Up 1.8 %

NASDAQ WBA opened at $22.63 on Tuesday. Walgreens Boots Alliance has a 52 week low of $19.68 and a 52 week high of $37.13. The company has a quick ratio of 0.30, a current ratio of 0.66 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $23.91 and its 200-day simple moving average is $23.53. The firm has a market cap of $19.52 billion, a PE ratio of 34.29, a P/E/G ratio of 1.37 and a beta of 0.74.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. The firm had revenue of $36.70 billion during the quarter, compared to the consensus estimate of $34.95 billion. Walgreens Boots Alliance had a return on equity of 10.48% and a net margin of 0.40%. The company’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period last year, the company earned $1.16 EPS. As a group, equities analysts anticipate that Walgreens Boots Alliance will post 3.25 earnings per share for the current year.

Walgreens Boots Alliance Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Stockholders of record on Tuesday, February 20th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.42%. The ex-dividend date of this dividend is Friday, February 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 290.91%.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the purchase, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Walgreens Boots Alliance news, CEO Timothy C. Wentworth bought 10,000 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The stock was purchased at an average price of $24.22 per share, for a total transaction of $242,200.00. Following the completion of the purchase, the chief executive officer now directly owns 585,122 shares in the company, valued at $14,171,654.84. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Valerie B. Jarrett acquired 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Financial Partners Group LLC lifted its stake in Walgreens Boots Alliance by 13.8% in the fourth quarter. Financial Partners Group LLC now owns 56,296 shares of the pharmacy operator’s stock valued at $1,470,000 after buying an additional 6,816 shares during the last quarter. Pingora Partners LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at approximately $1,015,000. Isthmus Partners LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $202,000. Treasurer of the State of North Carolina increased its holdings in shares of Walgreens Boots Alliance by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 326,917 shares of the pharmacy operator’s stock valued at $8,536,000 after purchasing an additional 3,100 shares during the period. Finally, Stifel Financial Corp increased its holdings in shares of Walgreens Boots Alliance by 14.0% in the fourth quarter. Stifel Financial Corp now owns 853,310 shares of the pharmacy operator’s stock valued at $22,280,000 after purchasing an additional 104,783 shares during the period. Hedge funds and other institutional investors own 57.92% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Get Free Report

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.